COMBINATION ANTRIRETROVIRAL REGIMENS AND TREATMENT-SWITCHING STRATEGIES IN CHILD

本子项目是利用由NIH/NCRR资助的中心赠款提供的资源的众多研究子项目之一。子项目和研究者（PI）可能已经从另一个NIH来源获得了主要资金，因此可以在其他CRISP条目中表示。列出的机构是中心的，不一定是研究者的机构。本研究的目的是评估两种不同的抗hiv药物治疗组合，并确定从一种治疗组合切换到另一种治疗组合的两种方案中哪一种更好。这项研究将评估在为期四年的治疗中，两种转换计划中的任何一种是否有不同的益处。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this research study is to evaluate two different treatment combinations of anti-HIV drugs, and to determine which of two plans for switching from one to the other treatment combination is better. The study will evaluate if there is a difference in benefit for either of the two switching plans in a four-year treatment.